|
|
Gilead Sciences Inc (GILD) |
|
|
|
Gilead Sciences Inc 's Yearly Net Income Growth 5 Years |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual Net Income Annual Growth Rates Y/Y▼
|
Annual Net Income Annual Growth Rates Y/Y▼
|
GILD Annual Net Income Growth |
2023
|
2022
|
2021
|
2020
|
2019
|
Y / Y Annual Net Income Change |
22.93 % |
-26.37 % |
6867.42 % |
-98.34 % |
-1.76 % |
Annual Net Income (in millions $) |
$5,613.00 |
$4,566.00 |
$6,201.00 |
$89.00 |
$5,364.00 |
Annual Net Income Growth
Comment |
Gilead Sciences Inc 's Annual Net Income for the fiscal year ended 2023, jumped by 22.93% to $5,613.00 millions, from $4,566.00 millions achieved a year ago. Gilead Sciences Inc 's growrh rate for Net Income improved from -26.37 % decline in the fiscal year 2022.
Gilead Sciences Inc Annual Income Statement
|
You need to upgrade your Flash Player
|
Companies with similar 2023 Annual Net Income within Healthcare Sector | Y/Y Net Income Growth % | 2023 Annual Net Income | Pfizer Inc | -93.13 % | $ 2,158.000 millions | Johnson and Johnson | 95.94 % | $ 35,153.000 millions | Biontech Se | -90.14 % | $ 1,041.936 millions | Novartis Ag | 113.57 % | $ 14,854.000 millions | Biogen Inc | -60.78 % | $ 1,161.500 millions | Zoetis Inc | 10.85 % | $ 2,340.000 millions | Becton Dickinson And Company | -16.58 % | $ 1,484.000 millions | Takeda Pharmaceutical Company Limited | 30.34 % | $ 2,196.436 millions | Edwards Lifesciences Corporation | -8.05 % | $ 1,399.400 millions | Intuitive Surgical Inc | 35.18 % | $ 1,817.300 millions | Agilent Technologies inc | -1.12 % | $ 1,240.000 millions | Iqvia Holdings Inc | 24.47 % | $ 1,358.000 millions | Quest Diagnostics Inc | -10.54 % | $ 908.000 millions | Fresenius Medical Care Ag | -18.10 % | $ 820.353 millions | Tenet Healthcare Corp | 30.97 % | $ 1,311.000 millions | Organon and Co | 11.56 % | $ 1,023.000 millions | Mettler toledo International Inc | -9.60 % | $ 788.778 millions | Davita Inc | 22.43 % | $ 956.978 millions | Resmed Inc | 15.15 % | $ 897.556 millions | United Therapeutics Corporation | 35.40 % | $ 984.800 millions | Boston Scientific Corporation | 128.08 % | $ 1,592.000 millions | Idexx Laboratories Inc | 24.44 % | $ 845.042 millions | West Pharmaceutical Services Inc | 1.28 % | $ 593.400 millions | Revvity Inc | 21.77 % | $ 693.094 millions | Vir Biotechnology Inc | | | |